Trial Profile
Efficacy, tolerability and quality of life in early cohorts of patients commencing everolimus in clinical practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2015 New trial record